Startup Fundraising•

Prodoc AI Raises Seed Funding for Hospital Workflow AI

Prodoc AI lands seed investment from Dr A. Velumani Family Office to advance its AI platform for streamlining hospital operations and patient engagement.

Share:
AM
Alvaro de la Maza

Partner at Aninver

Stay ahead of the market

Get instant notifications when new news matching "Healthcare, Healthtech & Medtech, Artificial Intelligence (AI) in India" are published.

Key Takeaways

  • Prodoc AI raised a new round (Seed) from Dr A. Velumani Family Office.
  • Sector: Healthcare, Healthtech & Medtech, Artificial Intelligence (AI), Technology, Software & Gaming.
  • Geography: India.

Analysis

Prodoc AI, a Bengaluru-based innovator in healthcare technology, has successfully closed a seed funding round led by the prominent Dr A. Velumani Family Office. The investment, which also saw participation from existing customers Dr Kunal Shet and Parth D. Bhasin, will fuel the company's expansion of its AI-powered platform designed to streamline operations within hospitals.

The company's core offering, termed a 'Patient Journey OS', addresses a critical inefficiency in the Indian healthcare sector. Many hospitals operate disparate systems for patient management, electronic health records, billing, and communication. Prodoc AI bridges these silos by creating an intelligent layer that maintains patient context across all touchpoints, from initial appointment booking to post-treatment follow-ups. This approach avoids the costly and time-consuming process of replacing existing infrastructure.

This funding arrives as Prodoc AI demonstrates significant traction, having previously raised approximately ₹1.7 crore across two angel rounds since its 2022 inception. The capital has enabled the company to integrate with over 100 hospitals, manage more than a million patient interactions monthly, and establish over fifty software integrations. This operational scale, achieved with modest prior funding, highlights the platform's efficiency and market fit, particularly for mid-market and regional hospital groups like MGM Healthcare, Ujala Cygnus, and Madhavbaug.

The strategic investment from Dr A. Velumani, founder of the highly successful diagnostics giant Thyrocare, underscores the potential of Prodoc AI's model. Dr. Velumani, who previously exited Thyrocare for over ₹4,500 crore, identified a key bottleneck in healthcare revenue conversion. He believes Prodoc AI can significantly reduce customer acquisition costs by 10% to 25% and enhance staff productivity, allowing a single employee to manage tasks previously requiring five. This aligns with his proven expertise in optimizing throughput and utilization within healthcare services.

Prodoc AI's technology encompasses modules for patient acquisition, outpatient and inpatient care coordination, retention strategies, referral management, and advanced voice AI capabilities. The company also emphasizes compliance with data protection regulations, holding certifications such as ISO 27001 and HIPAA, and supporting industry standards like HL7 FHIR and India's health-stack protocols. This robust technical foundation is crucial for building trust and ensuring seamless integration within complex hospital IT environments.

Co-founders Asit Kumar Vidyarthi (CEO) and Raghuvamshi Thakur (COO) plan to deploy the new capital to enhance agentic AI functionalities, broaden system integrations, and develop agents capable of managing diverse hospital workflows, including care coordination, operations, and revenue cycle management. The company's focus on workflow automation and operational efficiency positions it well within the current Indian healthtech funding trend, which favors solutions that demonstrate clear distribution strength and operational impact over consumer-facing applications.